Advertisement

Topics

Acalabrutinib granted Breakthrough Therapy Designation for the Treatment of Mantle Cell Lymphoma

20:01 EDT 8 Aug 2017 | Cancer Connect

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for acalabrutinib for the treatment of patients with […]

The post Acalabrutinib granted Breakthrough Therapy Designation for the Treatment of Mantle Cell Lymphoma appeared first on .

Original Article: Acalabrutinib granted Breakthrough Therapy Designation for the Treatment of Mantle Cell Lymphoma

NEXT ARTICLE

More From BioPortfolio on "Acalabrutinib granted Breakthrough Therapy Designation for the Treatment of Mantle Cell Lymphoma"

Quick Search
Advertisement
 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...